Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIFITEGRAST vs LINAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LIFITEGRAST vs LINAGLIPTIN: Safety Overview

Metric LIFITEGRAST LINAGLIPTIN
Total FAERS Reports 13,412 7,762
Deaths Reported 234 726
Death Rate 1.7% 9.4%
Hospitalizations 282 2,794
Average Patient Age 64.8 yrs 70.2 yrs
% Female Patients 82.8% 51.8%
FDA Approval Date Aug 4, 2023 Aug 31, 2021
Manufacturer Bausch & Lomb Incorporated Novadoz Pharmaceuticals LLC
Route OPHTHALMIC ORAL
Marketing Status Prescription Prescription